329 related articles for article (PubMed ID: 10377069)
1. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.
Ito A; Tsao PS; Adimoolam S; Kimoto M; Ogawa T; Cooke JP
Circulation; 1999 Jun; 99(24):3092-5. PubMed ID: 10377069
[TBL] [Abstract][Full Text] [Related]
2. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
[TBL] [Abstract][Full Text] [Related]
3. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
[TBL] [Abstract][Full Text] [Related]
4. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
Novella S; Laguna-Fernández A; Lázaro-Franco M; Sobrino A; Bueno-Betí C; Tarín JJ; Monsalve E; Sanchís J; Hermenegildo C
Mol Cell Endocrinol; 2013 Jan; 365(1):11-6. PubMed ID: 22982060
[TBL] [Abstract][Full Text] [Related]
5. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
Jiang JL; Jiang DJ; Tang YH; Li NS; Deng HW; Li YJ
Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
[TBL] [Abstract][Full Text] [Related]
6. Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype.
Smith CL; Birdsey GM; Anthony S; Arrigoni FI; Leiper JM; Vallance P
Biochem Biophys Res Commun; 2003 Sep; 308(4):984-9. PubMed ID: 12927816
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
9. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
Lin Y; Feng M; Lu CW; Lei YP; He ZM; Xiong Y
Eur J Pharmacol; 2017 Mar; 798():43-48. PubMed ID: 28163022
[TBL] [Abstract][Full Text] [Related]
10. [Effect of puerarin on ADMA-DDAH system in human umbilical vein endothelial cells cultured with oxidized free radical].
Li JX; Chen J; Deng ZH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Dec; 26(12):1103-6. PubMed ID: 17205823
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
Wu Y; Zhang JJ; Li TB; Liu WQ; Li LS; Luo XJ; Jiang JL; Ma QL; Yang ZC; Peng J
J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):536-548. PubMed ID: 26911182
[TBL] [Abstract][Full Text] [Related]
12. [Protective effect of losartan on injury induced by ox-LDL in endothelial cells and the relationship with asymmetric dimethylarginine].
Xie QY; Sun ZL; Chen MF; Yang TL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):66-9. PubMed ID: 16562679
[TBL] [Abstract][Full Text] [Related]
13. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
Lu CW; Xiong Y; He P
Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
[TBL] [Abstract][Full Text] [Related]
14. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
[TBL] [Abstract][Full Text] [Related]
15. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
Yin QF; Fu SH; He P; Xiong Y
Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.
Stühlinger MC; Tsao PS; Her JH; Kimoto M; Balint RF; Cooke JP
Circulation; 2001 Nov; 104(21):2569-75. PubMed ID: 11714652
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
Tang WJ; Hu CP; Chen MF; Deng PY; Li YJ
Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942
[TBL] [Abstract][Full Text] [Related]
18. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ
J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity.
Yang TL; Chen MF; Luo BL; Xie QY; Jiang JL; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):401-7. PubMed ID: 15915325
[TBL] [Abstract][Full Text] [Related]
20.
Sundar UM; Ugusman A; Chua HK; Latip J; Aminuddin A
Front Pharmacol; 2019; 10():1033. PubMed ID: 31607906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
